Monographs: Pharmaceutical substances: Digoxin (Digoxinum)Molecular formula. C41H64O14 Relative molecular mass. 781.0 Graphic formula.
Chemical name. 3β-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl)-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)-oxy]-12β,14-dihydroxy-5β-card-20(22)-enolide; CAS Reg. No. 20830-75-5. Description. Colourless crystals or a white or almost white, crystalline powder; odourless. Solubility. Practically insoluble in water and ether R; freely soluble in pyridine R; slightly soluble in ethanol (~750 g/l) TS. Category. Cardiotonic. Storage. Digoxin should be kept in a well-closed container, protected from light. Additional information. CAUTION: Digoxin is extremely poisonous and should be handled with care. Requirements Definition. Digoxin contains not less than 95.0% and not more than 103.0% of C41H64O14, calculated with reference to the dried substance. Identity tests • Either tests A, B and D or tests B, C and D may be applied.
Specific optical rotation. Use a 0.10 g/mL solution in pyridine R; Sulfated ash. Not more than 1.0 mg/g. Loss on drying. Dry to constant weight at ambient temperature under reduced pressure (not exceeding 0.6 kPa or about 5 mm of mercury); it loses not more than 10 mg/g. Gitoxin. Dissolve about 5 mg, accurately weighed, in 1 mL of ethanol (~675 g/l) TS by heating gently, and dilute to 25 mL with a mixture of equal volumes of hydrochloric acid (~250 g/l) TS and glycerol R. Allow to stand for 1 hour. The absorbance of a 1-cm layer of this solution at 352 nm, when measured against a solvent cell containing a mixture of equal volumes of hydrochloric acid (~250 g/l) TS and glycerol R, is not more than 0.22 (preferably use 2-cm cells for the measurement and calculate the absorbance of a 1-cm layer); about 40 mg/g. Related substances. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography, using kieselguhr R1 as the coating substance and a mixture of 10 volumes of formamide R and 90 volumes of acetone R to impregnate the plate, dipping it about 5 mm beneath the surface of the liquid. After the solvent has reached a height of at least 15 cm, remove the plate from the chromatographic chamber and allow to stand for at least 5 minutes. Use the impregnated plate within 2 hours, carrying out the chromatography in the same direction as the impregnation. As the mobile phase, use a mixture of 50 volumes of xylene R, 50 volumes of ethylmethylketone R, and 4 volumes of formamide R. Apply separately to the plate 1 μl of each of 3 solutions in a mixture of equal volumes of methanol R and chloroform R containing (A) 5.0 mg of the test substance per mL, (B) 5.0 mg of digoxin RS per mL and (C) 0.25 mg of digitoxin RS per mL. Develop the plate for a distance of 12 cm. After removal of the plate from the chromatographic chamber, allow it to dry at 115 °C for 20 minutes, cool, spray with a mixture of 15 volumes of a solution of 25 g of trichloroacetic acid R in 100 mL of ethanol (~750 g/l) TS and 1 volume of a freshly prepared 30 mg/mL solution of tosylchloramide sodium R, and then heat the plate at 115 °C for 5 minutes. Allow to cool, and examine the chromatogram in daylight and in ultraviolet light (365 nm). Any spot obtained with solution A in ultraviolet light, other than the principal spot, is not more intense than that obtained with solution C. Assay. Dissolve about 0.05 g, accurately weighed, in sufficient methanol R to produce 25 mL; dilute 5.0 mL of this solution to 100 mL with methanol R. Place 5.0 mL of the dilute solution to be tested in a 25-mL volumetric flask, add 15 mL of alkaline trinitrophenol TS, and dilute to 25 mL with methanol R. Set aside for 30 minutes protected from light, and measure the absorbance in a 1-cm layer at the maximum of about 490 nm against a solvent cell containing a solution prepared by diluting 15 mL of alkaline trinitrophenol TS to 25 mL with methanol R. Calculate the amount of C41H64O14 in the substance being tested by comparison with digoxin RS, similarly and concurrently examined. Additional requirements for Digoxin for parenteral use Complies with the monograph for "Parenteral preparations". Bacterial endotoxins. Carry out the test as described under 3.4 Test for bacterial endotoxins; contains not more than 200.0 IU of endotoxin RS per mg. |